Recombinant Human TGF-beta 1 Biotinylated Protein, CF

Recombinant Human TGF-beta 1 Biotinylated Protein, CF Summary

Product Specifications

Product Datasheets

Carrier Free

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Background: TGF-beta 1

TGF‑ beta 1 (transforming growth factor beta 1) is one of three closely related mammalian members of the large TGF‑ beta superfamily that share a characteristic cystine knot structure (1‑7). TGF‑beta 1, 2 and 3 are highly pleiotropic cytokines that are proposed to act as cellular switches that regulate processes such as immune function, proliferation and epithelial‑mesenchymal transition (1‑4). Each TGF‑ beta isoform has some non‑redundant functions; for TGF‑beta 1, mice with targeted deletion show defects in hematopoiesis and endothelial differentiation, and die of overwhelming inflammation (2). Human TGF‑beta 1 cDNA encodes a 390 amino acid (aa) precursor that contains a 29 aa signal peptide and a 361 aa proprotein (8). A furin-like convertase processes the proprotein to generate an N‑terminal 249 aa latency‑associated peptide (LAP) and a C‑terminal 112 aa mature TGF‑beta 1 (8, 9). Disulfide-linked homodimers of LAP and TGF‑beta 1 remain non‑covalently associated after secretion, forming the small latent TGF‑beta 1 complex (8‑10). Covalent linkage of LAP to one of three latent TGF‑beta binding proteins (LTBPs) creates a large latent complex that may interact with the extracellular matrix (9, 10). TGF‑beta is activated from latency by pathways that include actions of the protease plasmin, matrix metalloproteases, thrombospondin 1 and a subset of integrins (10). Mature human TGF‑beta 1 shares 100% aa identity with pig, dog and cow TGF‑beta 1, and 99% aa identity with mouse, rat and horse TGF‑beta 1. It demonstrates cross‑species activity (1). TGF‑beta 1 signaling begins with high‑affinity binding to a type II ser/thr kinase receptor termed TGF‑beta RII. This receptor then phosphorylates and activates a second ser/thr kinase receptor, TGF‑beta RI (also called activin receptor‑like kinase (ALK) ‑5), or alternatively, ALK‑1. This complex phosphorylates and activates Smad proteins that regulate transcription (3, 11, 12). Contributions of the accessory receptors betaglycan (also known as TGF-beta RIII) and endoglin, or use of Smad-independent signaling pathways, allow for disparate actions observed in response to TGF‑beta in different contexts (11).

Related Research Areas

• Airway Inflammation and Remodeling
• Alpha Granule Soluble Molecules
• Cancer Biomarkers
• Cytokines and Receptors in Allergy and Asthma
• Cytokines and Receptors in Angiogenesis
• Early Mesodermal Lineage Markers
• EMT Induction
• HIF Transcription Factors
• Inflammatory Mediators
• Microglia Activation Markers
• Microglia Homeostasis
• Myeloid-derived Suppressor Cells (MDSC)
• Neuroinflammatory Factors
• Preeclampsia
• Regulatory T Cells (Tregs)
• Search Cytokine and Growth Factor Products
• TGF-beta Family
• TGF-beta Family Ligands